References
- Williams ED, Sandler M. The classification of carcinoid tumors. Lancet 1963; 1: 238–9
- Rindi G, Capella C, Solcia E. Cell biology, clinicopathological profile, and classification of gastro-enteropancreatic endocrine tumors. J Mol Med 1998; 76(6)413–20
- Wilander E, Lundqvist M, El-Salhy M. Serotonin in Fore-Gut Carcinoids. A Survey of 60 Cases With Regard to Silver Stains, Formalin-Induced Fluorescence and Serotonin Immunocytochemistry. J Pathol 1985; 145(3)251–8
- Cai Y-C, Banner B, Glickman J, Odze RD. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol 2001; 32(10)1087–93
- Oliveira AM, Tazelaar HD, Myers JL, Erickson LA, Lloyd RV. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 2001; 25(6)815–9
- Sturm N, Rossi G, Lantuejoul S, Papotti M, Frachon S, Claraz C, et al. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol 2002; 33(2)175–82
- Du EZ, Goldstraw P, Zacharias J, Tiffet O, Craig PJ, Nicholson AG, et al. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 2004; 35(7)825–31
- Bostwick DG, Bensch KG. Gastrin releasing peptide in human neuroendocrine tumours. J Pathol 1985; 147(4)237–44
- Scott N, Millward E, Cartwright EJ, Preston SR, Coletta PL. Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours. J Clin Pathol 2004; 57(2)189–92
- Granberg D, Wilander E, Öberg K, Skogseid B. Prognostic Markers in Patients With Typical Bronchial Carcinoid Tumors. J Clin Endocrinol Metab 2000; 85(9)3425–30
- Warren WH, Memoli VA, Gould VE. Immunohistochemical and Ultrastructural Analysis of Bronchopulmonary Neuroendocrine Neoplasms. I. Carcinoids. Ultrastruct Pathol 1984; 6(1)15–27
- Warren WH, Memoli VA, Gould VE. Immunohistochemical and Ultrastructural Analysis of Bronchopulmonary Neuroendocrine Neoplasms. II. Well-Differentiated Neuroendocrine Carcinomas. Ultrastruct Pathol 1984; 7: 185–99
- Warren WH, Gould VE, Faber LP, Kittle CF, Memoli VA. Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants. J Thorac Cardiovasc Surg 1985; 89(6)819–25
- Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB, Jr, Niemann L, et al. Neuroendocrine Tumors of the Lung With Proposed Criteria for Large-Cell Neuroendocrine Carcinoma. An Ultrastructural, Immunohistochemical, and Flow Cytometric Study of 35 Cases. Am J Surg Pathol 1991; 15(6)529–53
- Willey JC, Lechner JF, Harris CC. Bombesin and the C-Terminal Tetradecapeptide of Gastrin-releasing Peptide are Growth Factors for Normal Human Bronchial Epithelial Cells. Exp Cell Res 1984; 153: 245–8
- Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 1985; 316(6031)823–6